These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 9506718

  • 1. Pulsatile luteinizing hormone secretion in patients with Addison's disease. Impact of glucocorticoid substitution.
    Hangaard J, Andersen M, Grodum E, Koldkjaer O, Hagen C.
    J Clin Endocrinol Metab; 1998 Mar; 83(3):736-43. PubMed ID: 9506718
    [Abstract] [Full Text] [Related]

  • 2. The effects of endogenous opioids and cortisol on thyrotropin and prolactin secretion in patients with Addison's disease.
    Hangaard J, Andersen M, Grodum E, Koldkjaer O, Hagen C.
    J Clin Endocrinol Metab; 1999 May; 84(5):1595-601. PubMed ID: 10323386
    [Abstract] [Full Text] [Related]

  • 3. Pulsatile thyrotropin secretion in patients with Addison's disease during variable glucocorticoid therapy.
    Hangaard J, Andersen M, Grodum E, Koldkjaer O, Hagen C.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2502-7. PubMed ID: 8675567
    [Abstract] [Full Text] [Related]

  • 4. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
    Bergendahl M, Aloi JA, Iranmanesh A, Mulligan TM, Veldhuis JD.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
    [Abstract] [Full Text] [Related]

  • 5. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
    Thomas MA, Rebar RW, LaBarbera AR, Pennington EJ, Liu JH.
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
    [Abstract] [Full Text] [Related]

  • 6. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G, Weekers F, Baxter RC, Wouters P, Iranmanesh A, Bouillon R, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [Abstract] [Full Text] [Related]

  • 7. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea.
    Berga SL, Mortola JF, Girton L, Suh B, Laughlin G, Pham P, Yen SS.
    J Clin Endocrinol Metab; 1989 Feb; 68(2):301-8. PubMed ID: 2493024
    [Abstract] [Full Text] [Related]

  • 8. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
    Fabbri A, Jannini EA, Ulisse S, Gnessi L, Moretti C, Frajese G, Isidori A.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
    [Abstract] [Full Text] [Related]

  • 9. Luteinizing hormone secretion and corticotropin-releasing factor gene expression in the paraventricular nucleus of rhesus monkeys following cortisol synthesis inhibition.
    Van Vugt DA, Piercy J, Farley AE, Reid RL, Rivest S.
    Endocrinology; 1997 Jun; 138(6):2249-58. PubMed ID: 9165008
    [Abstract] [Full Text] [Related]

  • 10. Effects of Gn-RH, TRH, and CRF administration on plasma leptin levels in lean and obese women.
    Komorowski J, Jankiewicz-Wika J, Stepień H.
    Neuropeptides; 2000 Apr; 34(2):89-97. PubMed ID: 10985925
    [Abstract] [Full Text] [Related]

  • 11. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate.
    Gindoff PR, Ferin M.
    Endocrinology; 1987 Sep; 121(3):837-42. PubMed ID: 3113919
    [Abstract] [Full Text] [Related]

  • 12. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA, Livesey JH, Florkowski C, Or HK, Donald RA, Espiner EA.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
    [Abstract] [Full Text] [Related]

  • 13. Prolactin pulsatile characteristics in postmenopausal women.
    Katznelson L, Riskind PN, Saxe VC, Klibanski A.
    J Clin Endocrinol Metab; 1998 Mar; 83(3):761-4. PubMed ID: 9506722
    [Abstract] [Full Text] [Related]

  • 14. Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects.
    Sheldon WR, DeBold CR, Evans WS, DeCherney GS, Jackson RV, Island DP, Thorner MO, Orth DN.
    J Clin Endocrinol Metab; 1985 Apr; 60(4):623-30. PubMed ID: 2982903
    [Abstract] [Full Text] [Related]

  • 15. Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease.
    Arvat E, Ramunni J, Maccagno B, Giordano R, Broglio F, Deghenghi R, Boscaro M, Ghigo E.
    Neuroendocrinology; 1999 Sep; 70(3):200-6. PubMed ID: 10516483
    [Abstract] [Full Text] [Related]

  • 16. Hypothalamic-pituitary function in diverse hyperprolactinemic states.
    Boyar RM, Kapen S, Finkelstein JW, Perlow M, Sassin JF, Fukushima DK, Weitzman ED, Hellman L.
    J Clin Invest; 1974 Jun; 53(6):1588-98. PubMed ID: 4208470
    [Abstract] [Full Text] [Related]

  • 17. Effects of dexamethasone and dexamethasone plus naltrexone on pituitary response to GnRH and TRH in normal women.
    la Marca A, Torricelli M, Morgante G, Lanzetta D, De Leo V.
    Horm Res; 1999 Jun; 51(2):85-90. PubMed ID: 10352398
    [Abstract] [Full Text] [Related]

  • 18. Sex steroids and pulsatile luteinizing hormone release in men. Studies in estrogen-treated agonadal subjects and eugonadal subjects treated with a novel nonsteroidal antiandrogen.
    Gooren L, Spinder T, Spijkstra JJ, van Kessel H, Smals A, Rao BR, Hoogslag M.
    J Clin Endocrinol Metab; 1987 Apr; 64(4):763-70. PubMed ID: 3102546
    [Abstract] [Full Text] [Related]

  • 19. Alpha-melanocyte-stimulating hormone antagonizes the neuroendocrine effects of corticotropin-releasing factor and interleukin-1 alpha in the primate.
    Shalts E, Feng YJ, Ferin M, Wardlaw SL.
    Endocrinology; 1992 Jul; 131(1):132-8. PubMed ID: 1319315
    [Abstract] [Full Text] [Related]

  • 20. Muting of androgen negative feedback unveils impoverished gonadotropin-releasing hormone/luteinizing hormone secretory reactivity in healthy older men.
    Veldhuis JD, Zwart A, Mulligan T, Iranmanesh A.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):529-35. PubMed ID: 11158004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.